Past, Present, and Future Strategies in the Treatment of High-Grade Glioma in Children
暂无分享,去创建一个
[1] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[2] R. Mirimanoff,et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. , 2005, The New England journal of medicine.
[3] R. McLendon,et al. Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition. , 2005, Molecular cancer therapeutics.
[4] Audrey E. Evans,et al. The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: Results of a randomized trial , 1989, Journal of Neuro-Oncology.
[5] P. Burger,et al. Treatment of infants with malignant gliomas: The Pediatric Oncology Group Experience , 2004, Journal of Neuro-Oncology.
[6] James M Boyett,et al. The influence of central review on outcome associations in childhood malignant gliomas: results from the CCG-945 experience. , 2003, Neuro-oncology.
[7] P D Griffiths,et al. Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] James M Boyett,et al. Impact of Proliferation Index on Outcome in Childhood Malignant Gliomas: Results in a Multi-institutional Cohort , 2002, Neurosurgery.
[9] I. Pollack,et al. Expression of p53 and prognosis in children with malignant gliomas. , 2002, The New England journal of medicine.
[10] R. Kortmann,et al. Preradiation chemotherapy for pediatric patients with high‐grade glioma , 2002, Cancer.
[11] C. James,et al. Analysis of oncogene and tumor suppressor gene alterations in pediatric malignant astrocytomas reveals reduced survival for patients with PTEN mutations. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[12] Susan M. Chang,et al. Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] R. Mcgarry,et al. Chemotherapy response rates in recurrent/progressive pediatric glioma; results of a systematic review. , 1999, Anticancer research.
[14] R. Sanford,et al. Supratentorial malignant gliomas in childhood , 1997, Cancer.
[15] R. Zimmerman,et al. Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] J. Wisoff,et al. Survival of infants with malignant astrocytomas. A report from the childrens cancer group , 1995, Cancer.
[17] S. Bertolone,et al. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.